Apatinib for chemotherapy-refractory extensive-stage SCLC: a retrospective study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Works in Cancer Chemotherapy & Pharmacology, 2019, Vol 83, Issue 4
Results: 21
1
2
ABCB1 c.3435C>T polymorphism is associated with platinum toxicity: a preliminary study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
3
Prognostic impact of polypharmacy and drug interactions in patients with advanced cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
4
Phase I study of orally administered <sup>14</sup>Carbon-isotope labelled-vistusertib (AZD2014), a dual TORC1/2 kinase inhibitor, to assess the absorption, metabolism, excretion, and pharmacokinetics in patients with advanced solid malignancies.
- Published in:
- 2019
- By:
- Publication type:
- journal article
5
Pharmacokinetic and cytokine profiles of melanoma patients with dabrafenib and trametinib-induced pyrexia.
- Published in:
- 2019
- By:
- Publication type:
- journal article
6
Changes in skeletal muscle area and lean body mass during pazopanib vs sunitinib therapy for metastatic renal cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
7
D-dimer increase: an unfavorable factor for patients with primary liver cancer treated with TACE.
- Published in:
- 2019
- By:
- Publication type:
- journal article
8
Effect of aprepitant administration on CINV caused by cisplatin multi-day chemotherapy and pharmacokinetics of docetaxel.
- Published in:
- 2019
- By:
- Publication type:
- journal article
9
Folate pathway genetic polymorphisms modulate methotrexate-induced toxicity in childhood acute lymphoblastic leukemia.
- Published in:
- 2019
- By:
- Publication type:
- journal article
10
Cyclophosphamide dose adjustment based on body weight and albuminemia in elderly patients treated with R-mini-CHOP.
- Published in:
- 2019
- By:
- Publication type:
- journal article
11
Effect of niraparib on cardiac repolarization in patients with platinum-sensitive, recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
12
In vitro and in vivo anticancer effects of two quinoline-platinum(II) complexes on human osteosarcoma models.
- Published in:
- 2019
- By:
- Publication type:
- journal article
13
Influence of oral magnesium-containing supplement and antacid administration on hypomagnesemia induced by panitumumab.
- Published in:
- 2019
- By:
- Publication type:
- journal article
14
Population pharmacokinetics analysis of nivolumab in Asian and non-Asian patients with gastric and gastro-esophageal junction cancers.
- Published in:
- 2019
- By:
- Publication type:
- journal article
15
Encapsulation of a new quinoxaline derivative in PLGA alters the pattern of its anticancer potency and induces apoptosis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
16
Analysis of SPARC and TUBB3 as predictors for prognosis in esophageal squamous cell carcinoma receiving nab-paclitaxel plus cisplatin neoadjuvant chemotherapy: a prospective study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
17
Molecular targeting of HER2-overexpressing biliary tract cancer cells with trastuzumab emtansine, an antibody-cytotoxic drug conjugate.
- Published in:
- 2019
- By:
- Publication type:
- journal article
18
Upregulation of MTA1 expression by human papillomavirus infection promotes CDDP resistance in cervical cancer cells via modulation of NF-κB/APOBEC3B cascade.
- Published in:
- 2019
- By:
- Publication type:
- journal article
19
A phase Ib dose allocation study of oral administration of lucitanib given in combination with fulvestrant in patients with estrogen receptor-positive and FGFR1-amplified or non-amplified metastatic breast cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
20
Blockade of integrin β3 signals to reverse the stem-like phenotype and drug resistance in melanoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
21
SPP1 inhibition improves the cisplatin chemo-sensitivity of cervical cancer cell lines.
- Published in:
- 2019
- By:
- Publication type:
- journal article